Correlation Between Estrella Immunopharma and Immunome
Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Estrella Immunopharma and Immunome, you can compare the effects of market volatilities on Estrella Immunopharma and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Immunome.
Diversification Opportunities for Estrella Immunopharma and Immunome
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Estrella and Immunome is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Immunome go up and down completely randomly.
Pair Corralation between Estrella Immunopharma and Immunome
Assuming the 90 days horizon Estrella Immunopharma is expected to under-perform the Immunome. But the stock apears to be less risky and, when comparing its historical volatility, Estrella Immunopharma is 10.53 times less risky than Immunome. The stock trades about -0.58 of its potential returns per unit of risk. The Immunome is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 1,147 in Immunome on September 1, 2024 and sell it today you would earn a total of 208.00 from holding Immunome or generate 18.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 14.29% |
| Values | Daily Returns |
Estrella Immunopharma vs. Immunome
Performance |
| Timeline |
| Estrella Immunopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
| Immunome |
Estrella Immunopharma and Immunome Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Estrella Immunopharma and Immunome
The main advantage of trading using opposite Estrella Immunopharma and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.| Estrella Immunopharma vs. Tff Pharmaceuticals | Estrella Immunopharma vs. Eliem Therapeutics | Estrella Immunopharma vs. Inhibrx | Estrella Immunopharma vs. Enliven Therapeutics |
| Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world |